Broad-spectrum antiviral activity of antisense oligonucleotides targeting GBF1 against SARS-CoV-2 and influenza viruses | Synapse
March 3, 2026Open Access
Broad-spectrum antiviral activity of antisense oligonucleotides targeting GBF1 against SARS-CoV-2 and influenza viruses
Key Points
Broad-spectrum antiviral activity was observed against both SARS-CoV-2 and influenza viruses, showcasing the effectiveness of antisense oligonucleotides.
Specifically, antisense oligonucleotides targeting the gbf1 gene inhibited viral replication significantly in laboratory settings.
Evaluation included multiple types of viruses, providing a robust assessment of the treatment across various pathogens.
Future research may enable the development of powerful antiviral therapies based on this targeted approach against viral infections.